Sponsor Pipeline

Shanghai Mabgen Biopharmaceutical Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07348653 A Study of MG2512 Injection in Participants With Advanced Solid Tumors Advanced Solid Tumor Recruiting
Get alerts when Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free